Endocrine autoantibodies

Clinics in Laboratory Medicine

Volumn 24, Issue 1, 2004, Pages 275-303

  Devendra, Devasenan ^a   Yu, Liping ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; GLUTAMATE DECARBOXYLASE; IA ANTIBODY; INSULIN; THYROID PEROXIDASE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN;

ADDISON DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; CELIAC DISEASE; DIFFERENTIAL DIAGNOSIS; ENDOCRINE DISEASE; GRAVES DISEASE; HUMAN; HYPOPHYSITIS; IMMUNOFLUORESCENCE; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PATHOGENICITY; PREDICTION; PRIORITY JOURNAL; REVIEW; THYROIDITIS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; ENDOCRINE SYSTEM; ENDOCRINE SYSTEM DISEASES; HUMANS;

EID: 2442433620     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2004.01.012     Document Type: Review

References (145)

1. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197
2. Barnett A.H., Eff C., Leslie R.D., Pyke D.A. Diabetes in identical twins: a study of 200 pairs. Diabetologia. 20:1981;87-93
3. Atkinson M.A., Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 358:2001;221-229
4. Bennett S.T., Todd J.A. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet. 30:1996;343-370
5. Pugliese A., Zeller M., Fernandez A., et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type I diabetes. Nat Genet. 15:1997;293-297
6. Vafiadis P., Bennett S.T., Todd J.A., et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet. 15:1997;289-292
7. Pugliese A., Brown D., Garza D., et al. Self-antigen presenting cells expressing IDDM-associated autoantigens exist in both thymus and peripheral lymphoid organs in humans. J Clin Invest. 107:2001;555-564
8. Norris J.M., Beaty B., Klingensmith G., et al. Lack of association between early exposure to cow's milk protein and β-cell autoimmunity: Diabetes Autoimmunity Study in the Young (DAISY). JAMA. 276:1996;609-614
9. Murakami M., Iriuchijima T., Mori M. Diabetes mellitus and interferon-α therapy. Ann Intern Med. 123:1995;318
10. Moriyama H., Wen L., Abiru N., et al. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci USA. 99:2002;5539-5544
11. 3H recombinant human ligands. J Immunol Methods. 186:1995;89-99
12. Gianani R., Rabin D.U., Verge C.F., et al. ICA512 autoantibody radioassay. Diabetes. 44:1995;1340-1344
13. Yu L., Rewers M., Gianani R., et al. Anti-islet autoantibodies develop sequentially rather than simultaneously. J Clin Endocrinol Metab. 81:1996;4264-4267
14. Williams A.J., Bingley P.J., Bonifacio E., Palmer J.P., Gale E.A. A novel micro-assay for insulin autoantibodies. J Autoimmun. 10:1997;473-478
15. Yu L., Robles D.T., Abiru N., et al. Early expression of anti-insulin autoantibodies of man and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA. 97:2000;1701-1706
16. Palmer J.P., Asplin C.M., Clemons P., et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 222:1983;1337-1339
17. Baekkeskov S., Aanstoot H.-J., Christgau S., et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. [published erratum appears in Nature 1990;347:782] Nature. (347):1990;151-156
18. Rabin D.U., Pleasic S.M., Shapiro J.A., et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol. 152:1994;3183-3188
19. Rabin D.U., Pleasic S.M., Palmer-Crocker R., Shapiro J.A. Cloning and expression of IDDM-specific human autoantigens. Diabetes. 41:1992;183-186
20. Wasmeier C., Hutton J.C. Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem. 271:1996;18161-18170
21. Castano L., Russo E., Zhou L., Lipes M.A., Eisenbarth G.S. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J Clin Endocrinol Metab. 73:1991;1197-1201
22. Thomas N.M., Ginsberg-Fellner F., Mcevoy R.C. Strong association between diabetes and displacement of mouse anti-rat insulinoma cell monoclonal antibody by human serum in vitro. Diabetes. 39:1990;1203-1211
23. Karounos D.G., Wolinsky J.S., Thomas J.W. Monoclonal antibody to rubella virus capsid protein recognizes a β-cell antigen. J Immunol. 150:1993;3080-3085
24. r autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest. 22:1993;240-248
25. Roep B.O., Kallan A.A., Hazenbos W.L.W., et al. T-cell reactivity to 38kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet. 337:1991;1439-1441
26. Dotta F., Previti M., Lenti L., et al. GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule. Diabetologia. 38:1995;1117-1121
27. Karjalainen J., Martin J.M., Knip M., et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med. 327:1992;302-307
28. Pietropaolo M., Castano L., Babu S., et al. Islet cell autoantigen 69 kDa (ICA69): molecular cloning and characterization of a novel diabetes associated autoantigen. J Clin Invest. 92:1993;359-371
29. Elias D., Cohen I., Shechter Y., Spirer Z., Golander A. Antibodies to insulin receptor followed by anti-idiotype. Diabetes. 36:1987;348-354
30. Birk O.S., Elias D., Weiss A.S., et al. NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells. J Autoimmun. 9:1996;159-166
31. Lernmark Å, Freedman Z.R., Hofmann C., et al. Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med. 299:1978;375-380
32. Martin S., Wolf-Eichbaum D., Duinkerken G., et al. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med. 345:2001;1036-1040
33. Yang M., Charlton B., Gautam A.M. Development of insulitis and diabetes in B cell-deficient NOD mice. J Autoimmun. 10:1997;257-260
34. Serreze D.V., Fleming S.A., Chapman H.D., Richard S.D., Leiter E.H., Tisch R.M. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol. 161:1998;3912-3918
35. Noorchashm H., Lieu Y.K., Noorchashm N., et al. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol. 163:1999;743-750
36. Bottazzo G.F., Florin-Christensen A., Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 2:1974;1279-1283
37. Genovese S., Bonifacio E., McNally J.M., et al. Distinct cytoplasmic islet cell antibodies with different risks for type I (insulin-dependent) diabetes mellitus. Diabetologia. 35:1992;385-388
38. Thai A.-C., Eisenbarth G.S. Natural history of IDDM. Diabetes Rev. 1:1993;1-14
39. Neufeld M., Maclaren N.K., Riley W.J., et al. Islet cell and other organ-specific antibodies in US Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes. 29:1980;589-592
40. Schatz D., Krischer J., Horne G., et al. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest. 93:1994;2403-2407
41. Gianani R., Pugliese A., Bonner-Weir S., et al. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes. 41:1992;347-353
42. Mueller P.W., Bingley P.J., Bonifacio E., Steinberg K.K., Sampson E.J. Predicting type 1 diabetes using autoantibodies: the latest results from the diabetes autoantibody standardization program. Diabetes Technol Ther. 4:2002;397-400
43. Bonifacio E., Genovese S., Braghi S., et al. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia. 38:1995;816-822
44. Kim J., Richter W., Aanstoot H.J., et al. Differential expression of GAD65 and GAD67 in human, rat and mouse pancreatic islets. Diabetes. 42:1993;1799-1808
45. Gianani R., Jackson R., Eisenbarth G.S. Evidence that the autoantigen of restricted ICA is GAD. Diabetes Res Clin Prac. 14:(Suppl 1):1991;S13
46. Powers A.C., Bavik K., Tremble J., Daw K., Scherbaum W.A., Banga J.P. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders. Clin Exp Immunol. 118:1999;349-356
47. Christie M., Landin-Olsson M., Sundkvist G., Dahlquist G., Lernmark Å, Baekkeskov S. Antibodies to a Mr-64, 000 islet cell protein in Swedish children with newly diagnosed type I (insulin-dependent) diabetes. Diabetologia. 31:1988;597-602
48. Schmidli R.S., Colman P.G., Bonifacio E., Bottazzo G.F., Harrison L.C. High level of concordance between assays for glutamic acid decarboxylase antibodies: the first international glutamic acid decarboxylase antibody workshop. Diabetes. 43:1994;1005-1009
49. Yu L., Cuthbertson D.D., Maclaren N., Jackson R., Eisenbarth G.S., Krischer J. Expression of GAD65 or ICA512(IA-2) autoantibodies amongst cytoplasmic ICA positive relatives is associated with eligibility for DPT-1. Diabetes. 50:2001;1735-1740
50. Krischer J.P., Cuthbertson D.D., Yu L., et al. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab. 88:2003;103-108
51. Lan M.S., Lu J., Goto Y., Notkins A.L. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 13:1994;505-514
52. Kawasaki E., Yu L., Rewers M.J., Hutton J.C., Eisenbarth G.S. Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes. 47:1998;733-742
53. Farilla L., Tiberti C., Luzzago A., et al. Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes. Eur J Immunol. 32:2002;1420-1427
54. Ziegler A.-G., Hummel M., Schenker M., Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes. 48:1999;460-468
55. Hawa M.I., Fava D., Medici F., et al. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care. 23:2000;228-233
56. Graham J., Hagopian W.A., Kockum I., et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes. 51:2002;1346-1355
57. Sanjeevi C.B., Falorni A., Kockum I., Hagopian W.A., Lernmark Å. HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus. Diabet Med. 13:1996;209-217
58. Chen W., Bergerot I., Elliott J.F., et al. Evidence that a peptide spanning the B-C junction of proinsulin is an early autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol. 167:2001;4926-4935
59. Berson S.A., Yallow R.S. Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest. 38:1959;1996-2016
60. Hirata J., Tominaga M., Ito J.-I., Noguchi A. Spontaneous hypoglycemia with insulin autoimmunity in Graves' disease. Ann Intern Med. 2:1974;214-218
61. Di Mario U., Perfetti R., Anastasi E., et al. Autoantibodies to insulin do appear in non-diabetic patients with autoimmune disorders: comparison with anti-immunoglobulin antibodies and other autoimmune phenomena. Acta Endocrinol (Copenhagen). 122:1990;303-308
62. Castano L., Ziegler A.G., Ziegler R., Shoelson S., Eisenbarth G.S. Characterization of insulin autoantibodies in relatives of patients with type 1 diabetes. Diabetes. 42:1993;1202-1209
63. Greenbaum C., Palmer J.P., Kuglin B., Kolb H. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J Clin Endocrinol Metab. 74:1992;1040-1044
64. Vardi P., Ziegler A.G., Matthews J.H., et al. Concentration of insulin autoantibodies at onset of type I diabetes: inverse log-linear correlation with age. Diabetes Care. 11:1988;736-739
65. Kimpimaki T., Kulmala P., Savola K., et al. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab. 87:2002;4572-4579
66. Pugliese A., Bugawan T., Moromisato R., et al. Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes. J Clin Invest. 93:1994;2447-2452
67. Bonifacio E., Scirpoli M., Kredel K., Fuchtenbusch M., Ziegler A.G. Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. J Immunol. 163:1999;525-532
68. Abiru N., Maniatis A.K., Yu L., et al. Peptide and MHC specific breaking of humoral tolerance to native insulin with the B:9-23 peptide in diabetes prone and normal mice. Diabetes. 50:2001;1274-1281
69. Osman A.A., Uhlig H., Thamm B., Schneider-Mergener J., Mothes T. Use of the phage display technique for detection of epitopes recognized by polyclonal rabbit gliadin antibodies. FEBS Lett. 433:1998;103-107
70. Folgori A., Tafi R., Meola A., et al. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J. 13:1994;2236-2243
71. Devendra D, Galloway TS, Horton S, Evenden A, Keller U, Wilkin TJ. The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes. Diabetologia, in press.
72. Bonifacio E., Atkinson M., Eisenbarth G., et al. International Workshop on Lessons from Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes. 50:2001;2451-2458
73. Rapoport B., Chazenbalk G.D., Jaume J.C., McLachlan S.M. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev. 19:1998;673-716
74. Brix T.H., Kyvik K.O., Hegedus L. What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Thyroid. 8:1998;727-734
75. Barbesino G., Tomer Y., Concepcion E.S., Davies T.F., Greenberg D.A. Linkage analysis of candidate genes in autoimmune thyroid disease: II. Selected gender-related genes and the X-chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab. 83:1998;3290-3295
76. Weetman A.P. Graves' disease. N Engl J Med. 343:2000;1236-1248
77. Coles A.J., Wing M., Smith S., et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet. 354:1999;1691-1695
78. Davies T.F., Roti E., Braverman L.E., DeGroot L.J. Thyroid controversy-stimulating antibodies. J Clin Endocrinol Metab. 83:1998;3777-3785
79. Zakarija M., Mckenzie J.M., Eidson M.S. Transient neonatal hypothyroidism: characterization of maternal antibodies to the thyrotropin receptor. J Clin Endocrinol Metab. 70:1990;1239-1246
80. Baker J.R. Jr. Autoimmune endocrine disease. JAMA. 278:1997;1931-1937
81. Kloos R.T. Thyroiditis. Robert E.R. Conn's current therapy. 2002;634-641 WB Saunders, Philadelphia
82. Prentice L.M., Phillips D.I., Sarsero D., Beever K., McLachlan S.M., Smith B.R. Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol (Copenhagen). 123:1990;493-498
83. Demers L.M., Spencer C.A. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol. 58:2003;138-140
84. Endo T., Kaneshige M., Nakazato M., Kogai T., Saito T., Onaya T. Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity. Biochem Biophys Res Commun. 228:1996;199-202
85. Farrell R.J., Kelly C.P. Celiac sprue. N Engl J Med. 346:2002;180-188
86. Mylotte M., Egan-Mitchell B., McCarthy C.F., McNicholl B. Incidence of coeliac disease in the West of Ireland. BMJ. 1:1973;703-705
87. Johnston S.D., Watson R.G., McMillan S.A., Sloan J., Love A.H. Coeliac disease detected by screening is not silent - simply unrecognized. QJM. 91:1998;853-860
88. Catassi C., Ratsch I.M., Fabiani E., et al. High prevalence of undiagnosed coeliac disease in 5280 Italian students screen by antigliadin antibodies. Acta Paediatr. 84:1995;672-676
89. Howell M.D., Austin R.K., Kelleher D., Nepom G.T., Kagnoff M.F. An HLA-D region restriction fragment length polymorphism associated with celiac disease. J Exp Med. 164:1986;333-338
90. Lundin K.E., Gjertsen H.A., Scott H., Sollid L.M., Thorsby E. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol. 41:1994;24-27
91. Rolles C.J., Myint T.O., Sin W.K., Anderson M. Proceedings: family study of coeliac disease. Gut. 15:1974;827
92. Stenhammar L., Brandt A., Wagermark J. A family study of coeliac disease. Acta Paediatr Scand. 71:1982;625-628
93. Polanco I. Gluten sensitive enteropathy in Spain: genetic and environmental factors. Proceedings of the International Symposium on Genetics of Coeliac Disease. 1981;211-231 MTP Press, Lancaster (England)
94. Farre C., Humbert P., Vilar P., et al. Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group. Dig Dis Sci. 44:1999;2344-2349
95. Falchuk Z.M., Strober W. HL-A antigens and adult coeliac disease. Lancet. 2:1972;1310
96. Bao F., Feal R.M.S. Endocrine and organ specific autoimmunity. Eisenbarth G.S. 1999;85-96 RG Landes, Georgetown
97. Sjoberg K., Alm R., Ivarsson S.A., Lindstrom C., Eriksson S. Prevalence and clinical significance of gliadin antibodies in healthy children and adults. Scand J Gastroenterol. 29:1994;248-254
98. Maki M., Hallstrom O., Marttinen A. Reaction of human non-collagenous polypeptides with coeliac disease autoantibodies. Lancet. 338:1991;724-725
99. Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 120:2001;636-651
100. Williams A.J., Norcross A.J., Lock R.J., Unsworth D.J., Gale E.A., Bingley P.J. The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity. Diabetes Care. 24:2001;504-509
101. Shan L., Molberg O., Parrot I., et al. Structural basis for gluten intolerance in celiac sprue. Science. 297:2002;2275-2279
102. Sommers S.C. Adrenal glands: Anderson's pathology. Kissane J.M. 2002;1429-1450 CV Mosby, St. Louis
103. Betterle C., Scalici C., Presotto F., et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol. 117:1988;467-475
104. Betterle C., Volpato M., Greggio A.N., Presotto F. Type 2 polyglandular autoimmune disease (Schmitd's syndrome). J Pediatr Endocrinol Metab. 9:1996;113-123
105. Tanaka H., Perez M.S., Powell M., et al. Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay. J Clin Endocrinol Metab. 82:1997;1440-1446
106. Betterle C., Volpato M., Rees Smith B. II, et al. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab. 82:1997;939-942
107. Falorni A., Nikoshkov A., Laureti S., et al. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab. 80:1995;2752-2755
108. Betterle C., Volpato M., Pedini B., Chen S., Smith B.R., Furmaniak J. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays. J Clin Endocrinol Metab. 84:1999;618-622
109. Freeman M., Weetman A.P. T and B cell reactivity to adrenal antigens in autoimmune Addison's disease. Clin Exp Immunol. 88:1992;275-279
110. *04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab. 84:1999;328-335
111. Myhre A.G., Undlien D.E., Lovas K., et al. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. J Clin Endocrinol Metab. 87:2002;618-623
112. Gambelunghe G., Falorni A., Ghaderi M., et al. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J Clin Endocrinol Metab. 84:1999;3701-3707
113. Rebar R.W., Connolly H.V. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril. 53:1990;804-810
114. LaBarbera A.R., Miller M.M., Ober C., Rebar R.W. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol. 16:1988;115-122
115. Anderson J.R., Goudie R.B., Gray K., Stuart-Smith D.A. Immunological features of idiopathic Addison's disease: an antibody to cells producing steroid hormones. Clin Exp Immunol. 3:1968;107-117
116. Kim T.J., Anasti J.N., Flack M.R., Kimzey L.M., Defensor R.A., Nelson L.M. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol. 89:1997;777-779
117. Ho P.C., Tang G.W., Fu K.H., Fan M.C., Lawton J.W. Immunologic studies in patients with premature ovarian failure. Obstet Gynecol. 71:1988;622-626
118. Damewood M.D., Zacur H.A., Hoffman G.J., Rock J.A. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol. 68:1986;850-854
119. Irvine W.J., Chand M.M.M., Scarth L., et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet. 2:1968;883-887
120. Elder M., Maclaren N., Riley W. Gonadal autoantibodies in patients with hypogonadism and/or Addison's disease. J Clin Endocrinol Metab. 52:1981;1137-1142
121. Hoek A., Schoemaker J., Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev. 18:1997;107-134
122. Falorni A., Laureti S., Santeusanio F. Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am. 31:2002;369-389
123. Wheatcroft N.J., Toogood A.A., Li T.C., Cooke I.D., Weetman A.P. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol. 96:1994;122-128
124. Arif S., Vallian S., Farzaneh F., et al. Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab. 81:1996;4439-4445
125. *genotypes encoding aspirate at position 57 are associated with 3β-hydroxysteroid dehydrogenase autoimmunity in premature ovarian failure. J Clin Endocrinol Metab. 84:1998;1056-1060
126. Reimand K., Peterson P., Hyoty H., et al. 3beta-hydroxysteroid dehydrogenase autoantibodies are rare in premature ovarian failure. J Clin Endocrinol Metab. 85:2000;2324-2326
127. Thorpe E.S., Handley H.E. Chronic tetany and chronic mycelial stomatitis in a child aged four-and-one-half years. Am J Dis Child. 38:1929;328-338
128. Leonard M.F. Chronic idiopathic hypoparathyroidism with superimposed Addison's disease in a child. J Clin Endocrinol Metab. 6:1946;493-495
129. Whitaker J. The syndrome of familial juvenile hypoadrenocorticism, hypoparathyroidism and superficial moniliasis. J Endocrinol. 16:1956;1374-1387
130. Aaltonen J., Björses P., Sandkuijl L., Perheentupa J., Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet. 8:1994;83-87
131. Nagamine K., Peterson P., Scott H.S., et al. Positional cloning of the APECED gene. Nat Genet. 17:1997;393-398
132. Ahonen P., Koskimies S., Lokki M.L., Tiilikainen A., Perheentupa J. The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA- DR. J Clin Endocrinol Metab. 66:1988;1152-1157
133. Maclaren N.K., Neufeld M. Autoimmunity and endocrine diseases. Collu R. Pediatric endocrinology. 1981;597-631 Raven Press, New York
134. Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol Metab Clin North Am. 31:2002;295-320
135. Gylling M., Tuomi T., Bjorses P., et al. Beta-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 85:2000;4434-4440
136. Hedstrand H., Ekwall O., Haavik J., et al. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochem Biophys Res Commun. 267:2000;456-461
137. Ekwall O., Hedstrand H., Haavik J., et al. Pteridin-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 85:2000;2944-2950
138. Neufeld M., Maclaren N.K., Blizzard R.M. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore). 60:1981;355-362
139. Maes M., Eisenbarth G.S. The polyglandular autoimmune syndromes. Volpé R. Contemporary endocrinology on autoimmune endocrinopathies. 1999;349-363 Humana Press, Totowa
140. Bosi E., Becker F., Bonifacio E., et al. Progression to type I diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes. 40:1991;977-984
141. Bevan J.S., Othman S., Lazarus J.H., Parkes A.B., Hall R. Reversible adrenocorticotropin deficiency due to probable autoimmune hypophysitis in a woman with postpartum thyroiditis. J Clin Endocrinol Metab. 74:1992;548-552
142. Pestell R.G., Best J.D., Alford F.P. Lymphocytic hypophysitis: the clinical spectrum of the disorder and evidence for an autoimmune pathogenesis. Clin Endocrinol. 33:1990;457-466
143. Thodou E., Asa S.L., Kontogeorgos G., Kovacs K., Horvath E., Ezzat K. Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab. 80:1995;2302-2311
144. Ozawa Y., Shishiba Y. Recovery from lymphocytic hypophysitis associated with painless thyroiditis: clinical implications of circulating antipituitary antibodies. Acta Endocrinol (Copenhagen). 128:1993;493-498
145. Crock P., Salvi M., Miller A., Wall J., Guyda H. Detection of anti-pituitary autoantibodies by immunoblotting. J Immunol Methods. 162:1993;31-40